InhaleRX snags $38.5M in funding from VC biotech funder Clendon
InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.
PPL
0.00%
6.0¢
Pumpkin Patch Ltd (In Receivership and in Liquidation) - News & Media
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No News & Media currently available.